Investor relations

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.

Observe Medical is listed on Euronext Oslo under OBSRV.

Read our latest regulatory news

Observe Medical ASA – Grant of options

Observe Medical ASA (the "Company") has on November 11, 2022, granted 1,000,000 share options in the Company to the group CEO, Rune Nystad. The options have been granted with an exercise price of NOK 4.5 per option share. The options will west in three tranches, whereby each tranche comprising 1/3 of the options will vest…

Read more

Observe Medical ASA: Third quarter 2022 results

Oslo, 3 November 2022 – Observe Medical ASA (“the Company” or “Observe Medical”) today release its results for the third quarter of 2022. "In October, we announced that Observe Medical had entered into an exclusive agreement with the intention to acquire Convatec’s Unometer urine measurement portfolio, consisting of several market-leading brand names such as Unometer™…

Read more

Financial calendar

  • 25 August 2022

    Quarterly Presentation - Q2 and First Half Report 2022

  • 3 November 2022

    Quarterly Presentation - Q3 2022

The Share

Share performance

Shareholders

As at 1 November 2022

NameNumber of shares% of top 20% of total Country
1INGERØ REITEN INVESTMENT COMPANY AS9,653,680 28.07%18.05%Norway
2NAVAMEDIC ASA4,222,727 12.28%7.89%Norway
3RO, LARS3,033,303 8.82%5.67%Norway
4JPB AS2,830,209 8.23%5.29%Norway
5ELI AS2,178,078 6.33%4.07%Norway
6NORDA ASA1,874,917 5.45%3.51%Norway
7MP PENSJON PK1,701,188 4.95%3.18%Norway
8UBS Switzerland AG1,445,547 4.20%2.70%Switzerland
9DNB BANK ASA1,180,400 3.43%2.21%Norway
10LAPAS AS805,185 2.34%1.51%Norway
11BJØRNTVEDT, VEGARD686,238 2.00%1.28%Norway
12SOLEGLAD INVEST AS586,668 1.71%1.10%Norway
13SILVERCOIN INDUSTRIES AS574,464 1.67%1.07%Norway
14Nordnet Bank AB554,499 1.61%1.04%Sweden
15HIMALAYA TANDORI AS550,000 1.60%1.03%Norway
16NORDNET LIVSFORSIKRING AS534,128 1.55%1.00%Norway
17TAJ HOLDING AS500,847 1.46%0.94%Norway
18GINNY INVEST AS500,000 1.45%0.93%Norway
19TRANBERGKOLLEN INVEST AS500,000 1.45%0.93%Norway
20BRØDRENE KARLSEN HOLDING AS479,868 1.40%0.90%Norway
Total number owned by top 20 34,391,946 100.00%64.29%
Total number of shares 53,491,656

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Euronext Expand Oslo

OBSRV

4 November 2019

Healthcare

NOK

NO0010865009

53 491 656

NOK 0.26

 

Governance

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.

For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no

2022

3 June 2022: Minutes from Annual General Meeting 2022

3 June 2022: Represented list

31 May 2022: Board of Directors recommendation for appointment of auditor

31 May 2022: The Nomination Committee recommendation part 2

13 May 2022: Notice of Annual General Meeting on 3 June 2022

13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022

13 May 2022: The Nomination Committee’s recommendation (part 1)

13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel

13 May 2022: Report on salary and other remuneration to executive personnel year 2021

13 May 2022: VPS – Investor services

13 May 2022: LUMI

13 May 2022: Online guide LUMI (Norsk)

13 May 2022: Online guide LUMI (English)

4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022

 

2021

21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021

30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021

30 April 2021: The Nomination Committee's recommendation

30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel

 

2020

30 June 2020: Annual General Meeting

16 June 2020: Extraordinary General Meeting

9 June 2020: Notice of Annual General Meeting on 30 June 2020

9 June 2020: Attendance to the Annual General Meeting on 30 June 2020

9 June 2020: Recommendation by the Nomination Committee

9 June 2020: The Boards declaration on remuneration to executive management

26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020

26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020

 

2019

24 October 2019: Extraordinary General Meeting

1 October 2019: Extraordinary General Meeting

5 August 2019: Extraordinary General Meeting

IR contact

Rune Nystad, Chief Executive Officer                                                                         +47 91 62 46 83 / rune.nystad@observemedical.com

Per Arne Nygård, Chief Financial Officer                                                              +47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list